Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis. | Hepatology | 2023 | 35921500 | PubTator, text mining | PubMed |
| Wnt signaling in liver regeneration, disease, and cancer. | Clin Mol Hepatol | 2023 | 35785913 | PubTator, text mining | PubMed |
| The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models. | Cancer Res Commun | 2022 | 36873622 | PubTator, text mining | PubMed |
| Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations. | Front Mol Biosci | 2022 | 36866106 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease. | J Oncol | 2022 | 36624801 | PubTator, text mining | PubMed |
| Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer Patients. | Int J Mol Sci | 2022 | 36613445 | PubTator, text mining | PubMed |
| To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL? | Cancers (Basel) | 2022 | 36612190 | PubTator, text mining | PubMed |
| Epigenetic Insights on PARP-1 Activity in Cancer Therapy. | Cancers (Basel) | 2022 | 36612003 | PubTator, text mining | PubMed |
| Notoginsenoside R1 Promotes Proliferation and Osteogenic Differentiation of hPDLSCs via Wnt/β-Catenin Signaling Pathway. | Drug Des Devel Ther | 2022 | 36583114 | PubTator, text mining | PubMed |
| The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells. | NPJ Precis Oncol | 2022 | 36575215 | PubTator, text mining | PubMed |
| Upregulation of Actin-Related Protein 2 (ACTR2) Exacerbated the Malignancy of Diffuse Large B-Cell Lymphoma through Activating Wnt Signaling. | Comput Math Methods Med | 2022 | 36570337 | PubTator, text mining | PubMed |
| Isogenic Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocytes Reveal Activation of Wnt Signaling Pathways Underlying Intrinsic Cardiac Abnormalities in Rett Syndrome. | Int J Mol Sci | 2022 | 36555252 | PubTator, text mining | PubMed |
| Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets. | Cancers (Basel) | 2022 | 36551731 | PubTator, text mining | PubMed |
| Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma. | Cancers (Basel) | 2022 | 36551696 | PubTator, text mining | PubMed |
| The people behind the papers - Anish Dattani and Ge Guo. | Development | 2022 | 36541650 | PubTator, text mining | PubMed |
| Synthesis of 1,5-Substituted Pyrrolidin-2-ones from Donor-Acceptor Cyclopropanes and Anilines/Benzylamines. | Molecules | 2022 | 36500574 | PubTator, text mining | PubMed |
| PARP1 Activation Controls Stress Granule Assembly after Oxidative Stress and DNA Damage. | Cells | 2022 | 36497190 | PubTator, text mining | PubMed |
| Relative Leukocyte Telomere Length and Genetic Variants in Telomere-Related Genes and Serum Levels Role in Age-Related Macular Degeneration. | Cells | 2022 | 36497103 | PubTator, text mining | PubMed |
| Inhibition of GSK3β Promotes Proliferation and Suppresses Apoptosis of Porcine Muscle Satellite Cells. | Animals (Basel) | 2022 | 36496849 | PubTator, text mining | PubMed |
| Principles and functions of condensate modifying drugs. | Front Mol Biosci | 2022 | 36483537 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers?page=17